Vystar Corp (VYST)

[Thai5533]

Vystar Corp VYST:OTCQB

It's Time To Look At UV-C Light Air Purification To Combat
COVID-19 More
Seriously
GlobeNewswire
8:45 AM ET

"It's time to look more seriously at UV-C light air
purification to help protect against airborne pathogens such
as COVID-19, influenza, and pneumonia," stated Dr. Bryan
Stone, MD, Internal Medicine and Nephrology, Chief of
Medicine Emeritus for Desert Regional Medical Center, and a
member of Vystar Corporation's (OTCQB: VYST) Board of
Directors.

The scientific and medical
communities, including the Centers for Disease Control
(CDC), agree that the primary method of COVID-19 and
influenza transmission is via airborne means.The cleanest
room is instantly contaminated the instant an infected
person enters and breaths, speaks, coughs or sneezes. "While
face masks and social distancing are good preventative
measures, we need additional measures, such as UV-C light
disinfection, to help prevent airborne transmission," Dr.
Stone observed. "This is particularly true in severe cold
weather areas where recommendations for socializing outdoors
or opening windows for added ventilation for extended
periods are not practical and/or possible."


Dr. Qanta Ahmed, MD, pulmonologist at NYU
Langone, also pushed for more use of UV-C light air
purifiers in an Oct. 26th Fox & Friends TV interview.
"Because we do have cold winters in the U.S., I would appeal
that the government looks into purifying indoor air," Dr.
Ahmed said. "We have amazing technology with UV light. Since
1978, we have known that that sterilizes the air... And they
kill 99.9% of viruses, including against the COVID 19 virus.
This is what we are going to need as we start to roll out
the vaccine. Indoor air is something we can work on now."


The CDC website "verifies that UV
germicidal irradiation has been employed in the disinfection
of drinking water, air, titanium implants, contact lenses
and in the healthcare environment (i.e., operating rooms,
isolation rooms, and biologic safety cabinets) for both
destruction of airborne organisms or inactivation of
microorganisms on surfaces."

Dr. Stone
warns, "It is extremely important to look for UV-C light air
purifiers that are FDA-cleared as Class II Medical Devices,
such as Vystar's RxAir 400(R) and Rx3000(R) air purifiers.
These devices have been tested in EPA and FDA-certified
laboratories as being effective and safe. To be effective,
units must use the correct UV-C bulb wavelength and
intensity and keep the air in close enough proximity to the
bulbs for the necessary duration. Many devices that quickly
pass air over small, low intensity UV lights are not
effective and can give a false sense of security that puts
users at risk."

How does UV-C light work
on COVID-19? - Coronaviruses, including SARS-CoV-2 which
causes COVID 19, are RNA viruses enveloped in a lipid
bilayer. UV-C light in the 254 nm wavelength inactivates
lipid viruses by damaging their DNA and RNA genetic
material. UV light's germicidal effectiveness is influenced
by UV intensity, which is affected by distance.


How does RxAir UV-C Light Air Purification
work? --The RxAir UV-C light air purifier is uniquely
effective because its patented "kill chamber" forces the air
to spiral in close proximity around the three 10-inch UV-C
tubes for an extended period of time, ensuring the proper
254 nm wavelength dosage for maximum microbicidal activity.


-- RxAir 400 UV Light air purifier -
inactivates or kills more than 99.9% of airborne viruses and
bacteria, providing up to six air changes per hour (ACH) for
an 800 to 1000 sq. ft. area.

-- Rx3000 UV
Light/HEPA air purifier - inactivates and captures 99.97% of
viruses and pathogens on first pass with four to eight ACH
for a 1500 sq. ft. surgical suite or infection control room
or four ACH for a 3000 sq. ft. non-surgical room.


RxAir air purifiers are portable
standalone units designed for use in a single room of a
home, classroom, office, healthcare facility, restaurant or
business. They can be valuable supplements to heating,
ventilation and air conditioning (HVAC) systems by providing
rooms with much higher ACH rates than the HVAC system while
inactivating, rather than trapping, the pathogens.


Dr. Stone noted, "RxAir devices also
reduce the number of active pathogens dropping onto
surfaces, thus reducing risk of contact transmission.
Another significant advantage is that RxAir UVC air
purifiers function free of the chemicals, smells and
residues that result from spray disinfectants."


Is UV light safe? --UV light is a known
carcinogen that can harm the eyes and skin from just moments
of direct exposure. RxAir protects consumers from exposure
to the UV light by enclosing the bulbs within the unit.
RxAir is completely safe for major reduction in ambient
level of airborne coronaviruses in occupied spaces. This is
a major contrast to UV-C robot- or ceiling- mounted
unshielded UV-C lights that can only be used in vacant
rooms.

UV-C Light and Indoor Air Quality
-- Research shows that in addition to viruses and bacteria,
allergenic pollens, mold, fungi and harmful pollutants
contribute to poor indoor air quality (IAQ) that causes
respiratory and heart disease, cancer, difficulty breathing,
headaches, dizziness, and asthma. RxAir UV-C light air
purifiers have been proven effective against harmful viral
and bacterial pathogens (including multiple coronaviruses,
H1N1, MRSA, pneumonia, strep, TB, measles, influenza, and
the common cold), molds, and fungi in addition to
neutralizing odors, VOCs (volatile organic compounds) and
other indoor pollutants.

Supplementary vs
Primary Disinfection -- The CDC currently recognizes UV-C
light disinfection as a supplementary disinfection method,
but that may change. Dr. Stone projected, "Just as the CDC
recently began to acknowledge that Coronavirus SARS CoV-2
has airborne transmission, I believe they will recognize
UV-C light as a primary disinfection method in occupied
spaces."

For information on how to become
an RxAir/Rx3000 distributor and/or bulk pricing, contact


Lee Howley, [e-mail]


Follow Vystar, Rx3000, RxAir and Vytex
news on social media:

Twitter:
@VystarCompany

#RxAir , #Coronavirus,
#Covid, #UVLight, #UVdisinfection


Sources:

Prather K.,
Marr L., Schooley R. et al., Airborne transmission of
SARS-CoV-2, Science, Oct. 5, 2020 doi:
10.1126/science.abf052,
https://science.sciencemag.org/content/early/2020/10/02/scien
e.abf0521/tab-pdf (Accessed Oct. 9, 2020)


Centers for Disease Control (2020, Oct 5)
SARS-CoV-2 & Potential Airborne Transmission


https://www.cdc.gov/coronavirus/2019-ncov/m
re/scientific-brief-sars-cov-2.html (Accessed Oct 30, 2020)


Centers for Disease Control --Infection
Control
https://www.cdc.gov/infectioncontrol/guidelines/disinfection/
isinfection-methods/miscellaneous.html (Accessed Oct 29,
2020)

Food & Drug Administration (March
2020) Enforcement Policy for Sterilizers, Disinfectant
Devices, and Air Purifiers During the Coronavirus Disease
2019 (COVID-19) Public Health Emergency,
https://www.fda.gov/regulatory-information/search-fda-guidanc
-documents/enforcement-policy-sterilizers-disinfectant-device
-and-air-purifiers-during-coronavirus-disease (Accessed Oct.
29, 2020)

Kowalski, Walsh, Petraitis
(2020, March) 2020 COVID-19 Coronavirus Ultraviolet
Susceptibility,
https://www.researchgate.net/publication/339887436_2020_COVID
19_Coronavirus_Ultraviolet_Susceptibility, Accessed October
10, 2020

Coffey, Donavyn, Does UV light
kill the new coronavirus?, (July 12, 2020) Live Science,
https://www.livescience.com/uv-light-kill-coronavirus.html,
(Accessed July 14, 2020)

Centers for
Disease Control (2020, April 29) Decontamination & Reuse of
Filtering Facepiece Respirators.
https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/de
ontamination-reuse-respirators.html. (Accessed July 21,
2020)

Sabino, Ball, Baptista, et al,
Enforcement Policy for Sterilizers, Disinfectant Devices,
and Air Purifiers During the Coronavirus Disease 2019
(COVID-19) Public Health Emergency, I, Nov. 2020,
do:10.1016/j.jphotobiol.2020.111999,
(https://www.sciencedirect.com/science/article/pii/S101113442
304498) (Accessed Oct 28, 2020)

Kowalski,
(2013, June) Residential Application of the RxAir UV light
Portable Air Purification Unit,
https://www.rxair.com/lab_results/residential-application/


Kowalski, (2009, Dec. 1) Prediction of
Virus Inactivation by the UV 400,
https://www.rxair.com/lab_results/virus-inactivation/


Kowalski, (2012, Jan20) Supplemental Air
Purification for Hospitals and Health Care Facilities,
https://www.rxair.com/lab_results/health-care-facilities/


National Environmental Education
Foundation, Bridger, C., National Public Health Week: The
Health Impacts of Indoor Air Quality,
https://www.neefusa.org/health/asthma/national-public-health-
eek-health-impacts-indoor-air-quality, (Accessed Oct. 27,
2020)

Financial Disclosure: Dr. Bryan
Stone is a shareholder of Vystar Corp.

#
# #

About Vystar Corporation:


Based in Worcester, Mass., Vystar Corp.
(OTCQB: VYST) is the majority owner of Rotmans Furniture and
Carpet and environmentally friendly technologies and
products to improve lives, such as RxAir UV light air
purification products, Vytex Natural Rubber Latex (NRL) and
Fluid Energy Solutions. Vystar is the exclusive creator of
Vytex, a multi-patented, all-natural, raw material that
contains significantly reduced levels of the proteins found
in natural rubber latex and can be used in over 40,000
products. Vytex NRL is a 100% renewable resource,
environmentally safe, "green" and fully biodegradable.
Vystar is working with manufacturers across a broad range of
consumer and medical products bringing Vytex NRL to market
in adhesives, gloves, balloons, condoms, other medical
devices and natural rubber latex foam mattresses, toppers,
and pillows. For more information, visit www.vytex.com.


Contacts:

Vystar


Media: Julie Shepherd, Accentuate PR, 847
275 3643, [e-mail]


Investors: Lee Howley, [e-mail]
508-791-9114

Distributor Opportunities:
Steve Rotman, CEO, [e-mail] 508-791-9114


Forward-looking Statements: Investors are
cautioned that certain statements contained in this document
as well as some statements in periodic press releases and
some oral statements of VYST officials are "Forward-Looking
Statements" within the meaning of the Private Securities
Litigation Reform Act of 1995 (the "Act"). Forward-looking
statements include statements which are predictive in
nature, which depend upon or refer to future events or
conditions, which include words such as "believes,"
"anticipates," "intends," "plans," "expects," and similar
expressions. In addition, any statements concerning future
financial performance (including future revenues, earnings
or growth rates), ongoing business strategies or prospects,
and possible future VYST actions, product development and
delivery, which may be provided by management, are also
forward-looking statements as defined by the Act.
Forward-looking statements involve known and unknown risks,
uncertainties, and other factors which may cause the actual
results, performance or achievements of the Company to
materially differ from any future results, performance, or
achievements expressed or implied by such forward-looking
statements and to vary significantly from reporting period
to reporting period. Although management believes that the
assumptions made and expectations reflected in the
forward-looking statements are reasonable, there is no
assurance that the underlying assumptions will, in fact,
prove to be correct or that actual future results will not
be different from the expectations expressed in this report.
These statements are not guarantees of future performance
and VYST has no specific intention to update these
statements.

Attachments


-- Vystar Corporation's


-- Vystar Corporation's


https://ml.globenewswire.com/media/7e4d1ec3
da41-490a-aa38-b76f8915752b/small/logo-jpg.jpg




============================================================

Past performance of a security, industry or sector does not
guarantee future results or
success.

Business Wire is a registered trademark of Business Wire.
GlobeNewswire is a registered trademark of The NASDAQ OMX
Group, Inc. PR Newswire is a registered trademark of PR
Newswire Association,
Inc.

Please do not reply to this e-mail from Markit On Demand.
Markit On Demand and TD Ameritrade are separate unaffiliated
companies and are not responsible for each other's service.
For questions regarding your brokerage account, please
contact TD Ameritrade Client Services at
1-800-669-3900.

To stop receiving this alert from TD Ameritrade, please
visit
https://research.ameritrade.com/grid/wwws/alerts/unsubscribe.asp?YYY600_43YYGH1ZYxCdI7TjCYzdUh0XiqQFTX0owgGHS93ar3D185hBClqrmcGRijBQWfoP6ieV3/zIwBdVY1mrdSUhJ+fLvaobp5fO0tZnsRTXWlvCZ2usrdbG6wvuTQo8ojuQ4KaHlWZUZsTAVruJ1cg2RGSeeWr0C/ntq58fu9/Cce6T8y6s7t/AQQ==&a=
to update your subscription settings. You may also
unsubscribe from all of your alerts using the link above. As
always, you can manage all of your alert settings by logging
into your TD Ameritrade account and navigating to Research &
Ideas >
Alerts.